Sellas Life Sciences: Behind The Big Surge [Seeking Alpha]
SELLAS Life Sciences Group, Inc. (SLS)
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm
Check Earnings Report
US:NYSE Investor Relations:
sellaslifesciences.com/investors/overview/default.aspx
Company Research
Source: Seeking Alpha
SLS's lead candidate, GPS, is in a pivotal Phase 3 trial (REGAL) for AML-CR2, with final data expected after the 80th event, likely in 1H26. Despite promising efficacy signals, SLS faces significant dilution risk, with shares outstanding up 219% in two years and further capital raises likely. An analysis around Sellas Life Sciences follows in the paragraphs below. Looking for a helping hand in the market? Members of The Biotech Forum get exclusive ideas and guidance to navigate any climate. Learn More » wildpixel/iStock via Getty Images Shares of cancer therapy concern Sellas Life Sciences Group, Inc. ( SLS have rallied more than 250% since a December 2025 low of $1.39 a share, as positive data from its two clinical assets have fortified investors. The market is More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive
Show less
Read more
Impact Snapshot
Event Time:
SLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLS alerts
High impacting SELLAS Life Sciences Group, Inc. news events
Weekly update
A roundup of the hottest topics
SLS
News
- SELLAS Life Sciences Group (SLS) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment [Yahoo! Finance]Yahoo! Finance
- SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run [Yahoo! Finance]Yahoo! Finance
SLS
Sec Filings
- 4/24/26 - Form SCHEDULE
- 4/23/26 - Form DEF
- 4/23/26 - Form DEFA14A
- SLS's page on the SEC website